Sort
3,198 grants matching “mrna vaccine”
Cytokines in AIDS and Cancer
$813,040George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Nucleoside-modified mRNA vaccine for prevention and treatment of genital herpes
$812,498Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2023 · AI
Nucleoside-modified mRNA vaccine for prevention and treatment of genital herpes
$812,498Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2025 · AI
Nucleoside-modified mRNA vaccine for prevention and treatment of genital herpes
$812,498Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2024 · AI
Core B: GMP Cell and RNA Manufacturing
$812,276Bruce L. Levine · University Of Pennsylvania · P01 · FY2019 · CA
Development of mRNA-platform vaccines
$812,208Fredrick Heath Damron · West Virginia University · R01 · FY2024 · AI
SARS-CoV-2 correlates of protection in a Latino-origin population
$812,000Carlos A Sariol · University Of Puerto Rico Med Sciences · U01 · FY2024 · CA
Harnessing CD4 T follicular helper 1 cells for HIV vaccine efficacy
$809,526Swaminathan Smita Iyer · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation
$808,735John R Kirby · University Of Iowa · R01 · FY2016 · AI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$808,122Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Natural Immunity Against Chlamydia trachomatis
$808,098Toni Darville · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Evolution of T cell immunity in blood and tissues over childhood
$807,646Donna L Farber · Columbia University Health Sciences · U01 · FY2025 · AI
Evolution of T cell immunity in blood and tissues over childhood
$807,646Donna L Farber · Columbia University Health Sciences · U01 · FY2024 · AI
Evolution of T cell immunity in blood and tissues over childhood
$807,646Donna L Farber · Columbia University Health Sciences · U01 · FY2023 · AI
Development of mRNA-platform vaccines
$807,427Fredrick Heath Damron · West Virginia University · R01 · FY2025 · AI
Establishing ferret models to optimize new influenza vaccines that replace original antigenic sin with initial blessings of induced immunity
$807,420Scott Eric Hensley · University Of Pennsylvania · R56 · FY2020 · AI
An improved low-endotoxin Clean Genome E. coli strain for production of biological products
$806,101David A Frisch · Scarab Genomics, Llc · R44 · FY2025 · GM
Oral transmission of KSHV using rhesus macaque rhadinovirus model
$805,884Scott W Wong · Oregon Health & Science University · R01 · FY2025 · CA
Lysine Acetylation in N. gonorrhoeae Quorum Sensing and Biofilm Formation
$805,715John R Kirby · University Of Iowa · R01 · FY2015 · AI
MOLECULAR SIGNATURES OF IMMUNE RESPONSE TO VACCINATION
$805,661Alan A Aderem · Emory University · U19 · FY2008 · AI
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity
$805,483James A Hoxie · University Of Pennsylvania · R01 · FY2018 · AI
Lipid nanoparticle adjuvants for mRNA vaccines: composition-function relation and mechanism of action
$803,514Norbert Pardi · University Of Pennsylvania · R01 · FY2025 · AI
Evaluation of Oropharyngeal responses to SARS-CoV-2
$803,248Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Exploiting the antigenic conservation of the Env trimer apex across primate lentiviral lineages for AIDS vaccine design
$802,998Beatrice H Hahn · University Of Pennsylvania · R01 · FY2021 · AI
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
$802,815Charles Bix Shoemaker · Tufts University Boston · R01 · FY2024 · AI